Capital expenditures in 2011 included tooling related to new product development, investments in our facilities including the new plant in China, technology upgrades, and manufacturing and lab equipment.Financing Activities ??? Net cash used for financing activities was $21.5 million in 2013, $34.9 million in 2012 and $24.2 million in 2011.